LY900014

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

34 regulatory and trial events tracked for LY900014, covering 2019-10-08 to 2025-10-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in India [Phase 4]